1.
Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, et al. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO). Acta Derm Venereol [Internet]. 2024 Sep. 5 [cited 2024 Sep. 18];104:adv40556. Available from: https://medicaljournalssweden.se/actadv/article/view/40556